Replies to post #24370 on $heff's $tation of $tocks & $olid DD

[thefranchise]

I agree every agent is different, but I think looking historically at the FDAs hard stance on sleep medication can't be ignored. I personally thought SOMX looked terrible compared to TSPT, and TSPT got denied. I wish every best of luck on it, and hope most got in around the alert so they can claim a profit here soon. I just wouldn't hold into approval. Hopefully it does get approved and everyone gets rich ;)

[$heff]

SOMX ($4.20)...closed strong after 3 straight days after struggling to get past the $4.00 barrier. I still believe that Silenor gets approved for insomnia even though the company has been denied the past two times. Everyone must do their own DD on this one as you never know what the FDA is going to do on these decisions. $heff